LYNNTECH INC. — Department of Defense SBIR Phase I: Platelets play a central role in hemostasis and are responsible for many inherited and acq
LYNNTECH INC. — SBIR Phase I award from Department of Defense.
- Amount
- $149,999
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase I
- Solicitation
- 2013.2
- NAICS
- —
- Place of performance
- TX
- Period
- 2014-01-27 → 2014-08-27
Description
Platelets play a central role in hemostasis and are responsible for many inherited and acquired bleeding disorders and thrombic events in human beings. A significant portion of post-trauma deaths are related to coagulopathy or hemorrhage events for both injured soldiers and civilian patients. Several platelet function analyzers have been designed and developed; however due to form-factor and/or limited analysis capabilities these systems do not function effectively as point-of-care (POC) instruments. There is a critical need to develop effective POC instrumentation for platelet function assessment to aid in minimizing patient mortality. Lynntech proposes to develop a novel, rapid, easy-to use, and cost effective POC device to simultaneously measure the individual platelet receptor contributions to platelet coagulation in whole blood through an electrochemical-fluidics system. The system automation will be designed such that a single, small blood sample will be fully analyzed within a disposable cartridge to minimize user effort and error.